Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas-ko ikertzaileekin lankidetzan egindako argitalpenak (35)

2024

  1. Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer

    Cell Death Discovery, Vol. 10, Núm. 1

2023

  1. Clinical feasibility of combining intraoperative electron radiation therapy with minimally invasive surgery: a potential for electron-FLASH clinical development

    Clinical and Translational Oncology, Vol. 25, Núm. 2, pp. 429-439

  2. Corrigendum: Practice-oriented solutions integrating intraoperative electron irradiation and personalized proton therapy for recurrent or unresectable cancers: Proof of concept and potential for dual FLASH effect, (Front. Oncol, (2022), 12, (1037262), 10.3389/fonc.2022.1037262)

    Frontiers in Oncology

  3. Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia

    Haematologica, Vol. 108, Núm. 10, pp. 2652-2663

  4. Precise dosimetric comparison between GAMOS and the collapsed cone convolution algorithm of 4D DOSE accumulated in lung SBRT treatments

    Radiation Physics and Chemistry, Vol. 208

2022

  1. BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up

    European Urology

  2. G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models

    Biomedicine and Pharmacotherapy, Vol. 150

  3. Generation of NKX2.5GFP Reporter Human iPSCs and Differentiation Into Functional Cardiac Fibroblasts

    Frontiers in Cell and Developmental Biology, Vol. 9

  4. Monte Carlo Simulation Framework for the Evaluation of PET Detector Designs in Charged Particle Therapy Applications

    2022 IEEE NSS/MIC RTSD - IEEE Nuclear Science Symposium, Medical Imaging Conference and Room Temperature Semiconductor Detector Conference

  5. Practice-oriented solutions integrating intraoperative electron irradiation and personalized proton therapy for recurrent or unresectable cancers: Proof of concept and potential for dual FLASH effect

    Frontiers in Oncology, Vol. 12

2021

  1. A tool for precise calculation of organ doses in voxelised geometries using GAMOS/Geant4 with a graphical user interface

    Polish Journal of Medical Physics and Engineering, Vol. 27, Núm. 1, pp. 31-40

  2. An Fc-free EGFR-specific 4-1BB-agonistic trimerbody displays broad antitumor activity in humanized murine cancer models without toxicity

    Clinical Cancer Research, Vol. 27, Núm. 11, pp. 3167-3177

  3. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

2020

  1. A proposal for a Geant4 physics list for radiotherapy optimized in physics performance and CPU time

    Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, Vol. 964

2019

  1. CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status

    Clinical Cancer Research, Vol. 25, Núm. 1, pp. 390-402

  2. Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status

    Scientific Reports, Vol. 9, Núm. 1

  3. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

    Nature Medicine

2017

  1. Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer

    Oncotarget, Vol. 8, Núm. 6, pp. 10531-10542

  2. UroMark—a urinary biomarker assay for the detection of bladder cancer

    Clinical Epigenetics, Vol. 9, Núm. 1

2015

  1. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer

    Oncotarget, Vol. 6, Núm. 39, pp. 42258-42275